Find More Contacts for Spark Therapeutics
Protected Content
Chief People Officer
Non-Management, Executive Finance, Human Resources
3 emails found 1 phone number found
View contacts for Spark Therapeutics to access new leads and connect with decision-makers.
View All Contacts
  • Contact Email info@sparktx.com
  • Phone Number +1 215-220-9300

Spark Therapeutics is developing potentially curative, one-time gene therapy products to transform the lives of patients and re-imagine the treatment of debilitating diseases.

The founding team includes scientists who have led the advancement of gene therapy over the past two decades, establishing human proof of concept of the expression of gene

therapy in the eye and liver.

Spark’s robust pipeline includes SPK-RPE65, a fully enrolled, pivotal Phase 3 program in blindness due to mutations in the RPE65 gene, SPK-CHM for the treatment of choroideremia, and SPK-FIX, a program for the potential treatment of hemophilia B through a global collaboration with Pfizer Inc., as well as preclinical programs to address neurodegenerative diseases and other retinal degenerative diseases and hematologic disorders.

Spark has rights to a proprietary manufacturing platform that has a track record supporting clinical studies across diverse therapeutic areas and routes of administration.

Spark’s expertise across research, clinical, regulatory and manufacturing builds on a legacy of innovation and excellence in gene therapy established by Spark’s team while at The Children’s Hospital of Philadelphia Center for Cellular and Molecular Therapeutics.

Lists Featuring This Company

Investment Bank Funded Companies (Top 10K)
9,966 Number of Organizations • $3.1T Total Funding Amount • 100,632 Number of Investors
Companies With Fewer Than 1000 Employees (Top 10K)
9,146 Number of Organizations • $1.5T Total Funding Amount • 100,334 Number of Investors
Great Lakes Acquired Companies With More Than 100 Employees
3,947 Number of Organizations • $154.8B Total Funding Amount • 2,408 Number of Investors
Northeastern US Companies With Fewer Than 1000 Employees (Top 10K)
9,971 Number of Organizations • $610.9B Total Funding Amount • 60,615 Number of Investors
Spark Therapeutics was acquired by Roche for $4.3B on Feb 25, 2019.

Frequently Asked Questions

Where is Spark Therapeutics's headquarters? Spark Therapeutics is located in Philadelphia, Pennsylvania, United States.Who invested in Spark Therapeutics? Spark Therapeutics has 7 investors including Brookside Capital and Sofinnova Investments.How much funding has Spark Therapeutics raised to date? Spark Therapeutics has raised .When was the last funding round for Spark Therapeutics? Spark Therapeutics closed its last funding round on Aug 3, 2017 from a Post-IPO Equity round.Who are Spark Therapeutics's competitors? Alternatives and possible competitors to Spark Therapeutics may include BridgeBioLoyal, and Kenai Therapeutics.